Humana Inc vs SoFi Technologies Inc — how do they compare? Humana Inc trades at $445 (market cap $47.61B), while SoFi Technologies Inc trades at $15.76 (market cap $20.23B). The key difference: Humana Inc is far larger — about 2.4× SoFi Technologies Inc's market cap, and Humana Inc pays a 0.89% dividend while SoFi Technologies Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and SoFi Technologies Inc for 60 Days on average.
| HUM | SOFI | |
|---|---|---|
Market Cap | $47.61B | $20.23B |
Volume | 1,827,332 | 32,692,405 |
Sector | Health | Financials |
52-Week High | $409.85 | $32.21 |
52-Week Low | $163.67 | $15.15 |
Typical Hold Time | 53 Days | 60 Days |
Enterprise Value | $54.97B | $20.37B |
Dividend Yield | 0.89% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
SOFI stock trades at $15.61, down 0.95% on the day, with a bearish technical signal and mixed sentiment. Revenue grew to $3.61B in 2025, with net income of $481.32M, but cash flow from operations remains negative. The company has beaten EPS estimates in recent quarters, with Q3 2026 results expected soon. Analyst consensus is a Buy with a $21.58 price target, though technical indicators suggest near-term pressure.
Outlook: SOFI offers growth potential with strong revenue expansion and a diversified fintech platform, but faces risks from negative operating cash flow, high valuation multiples, and sensitivity to interest rates. The stock's current discount to analyst targets may present opportunity, but investors should weigh execution risks and macroeconomic headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →